AB - IHC - CD8
View samplesTemplate
Attributes
| Name | Type | Description | PID  | Unit |
|---|---|---|---|---|
| UID* | Text | Not specified | - | - |
| Name | Text | Not specified | - | - |
| Catalog# | Text | Not specified | - | - |
| Vendor | Text | Not specified | - | - |
| Analyte | Text | Not specified | - | - |
| Fluorophore | Text | Not specified | - | - |
| ExperimentType | Text | Not specified | - | - |
| Isotype | Text | Not specified | - | - |
| SecondaryAntibody | Text | Not specified | - | - |
| SecondaryAntibodyLink | URI | Not specified | - | - |
| CatalogLink | URI | Not specified | - | - |
Tags
Not specified Creators and SubmitterViews: 202 Downloads: 4
Created: 12th Oct 2023 at 00:45
Last updated: 12th Oct 2023 at 00:45
TagsThis item has not yet been tagged.
AttributionsNone
Related items
Projects: Hi-IMPAcTB, MIT SRP, MetNet, Endometriosis, Cancer Systems Biology Consortium (CSBC)
Institutions: Massachusetts Institute of Technology
Projects: Hi-IMPAcTB
Web page: https://www.niaid.nih.gov/research/immune-mechanisms-protection-mycobacterium-tuberculosis
About
This project houses all the publicly available datasets generated by the Hi-IMPAcTB consortium over the course of its 7+ years.
What is Hi-IMPAcTB?
Hi-IMPAcTB is an ambitious endeavor bringing together a team of international, interdisciplinary researchers to improve our understanding of host-pathogen interactions in the context of tuberculosis (TB). Funded by a multi-center contract from the NIH, the long-term goal of the consortium is to enable principled vaccine design by improving ...
Programme: IMPAcTB
Public web page: https://grantome.com/grant/NIH/75N93019C00071-0-9999-1
